“Kenya and South Korea Unite in Unprecedented Move to Propel Domestic Vaccine and Pharmaceutical Production”

Within the realm of vaccines and pharmaceutical manufacturing, Kenya and South Korea have colluded to form a partnership. The two countries are set to exchange technology, health financing, management information systems, and health commodity security to boost this endeavor. A meeting held at Afya House in Nairobi saw the Cabinet Secretary for Health, Nakhumicha A. Wafula, hosting the visiting Health and Welfare committee members of Gyeonggi-do provincial government from South Korea, alongside the Baringo County Governor, Benjamin Cheboi. Governor Cheboi urged the Korean government to create employment opportunities for fresh graduates from health training institutions in his county during the meeting. The international community has much to gain from this partnership. Kenya intends to form the Kenya Biovax Institute, which will specialize in local vaccine and pharmaceutical manufacturing. Advantages of this initiative include reduced costs and availability of vaccines and pharmaceuticals, especially in remote areas. Last year, CS Wafula visited the International Vaccine Institute and SK Biosciences in Seoul, South Korea. Kenya formally sought admission to become a state party. The country also signed an agreement with Exim Bank last year to offer financial channels for people interested in going into vaccine and pharmaceuticals manufacturing.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept